Product
Travoprost + Brinzolamide
1 clinical trial
1 indication
Indication
Intraocular PressureClinical trial
A Double-Masked, Parallel-Group, Efficacy and Safety Study of Brinzolamide 1.0% (AZOPT) as Adjunctive Therapy to Travoprost 0.004% (TRAVATAN) in Patients With Chronic Angle-Closure GlaucomaStatus: Terminated, Estimated PCD: 2008-03-01